QP
NTLA icon

Quilter Plc’s Intellia Therapeutics NTLA Stock Holding History

Quilter Plc’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,350
Closed -$315K – 263
2021
Q3 		$315K Sell
2,350
-516
-18% -$78.1K 0.01% 220
2021
Q2 		$464K Buy
2,866
+51
+2% +$3.97K 0.01% 189
2021
Q1 		$226K Sell
2,815
-895
-24% -$60.1K 0.01% 288
2020
Q4 		$202K Buy
+3,710
New +$135K 0.01% 258

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quilter Plc's NTLA Position: Q4 2021 in Review

Quilter Plc sold out of Intellia Therapeutics (NTLA) in Q4 2021, closing a stake of 2,350 shares — an estimated $315K sold.

Quilter Plc first reported a position in NTLA in Q4 2020 and held it in 4 quarters. The position peaked at $464K in Q2 2021. 371 funds tracked by Wall St. Rank hold NTLA as of Q4 2021.

  • Quilter Plc reported no remaining Intellia Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Quilter Plc sold 2,350 Intellia Therapeutics shares in Q4 2021, an estimated $315K.
  • Quilter Plc first reported a position in Intellia Therapeutics in Q4 2020 and held it in 4 quarters.
  • Quilter Plc's Intellia Therapeutics position peaked at $464K in Q2 2021.
  • 371 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q4 2021.

Based on Quilter Plc's 13F filing for Q4 2021, filed 14 Feb 2022.